loadpatents
name:-0.026884078979492
name:-0.023098945617676
name:-0.0087640285491943
Zhang; Jiancun Patent Filings

Zhang; Jiancun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhang; Jiancun.The latest application filed is for "aromatic heterocyclic compound, and pharmaceutical composition and use thereof".

Company Profile
7.19.24
  • Zhang; Jiancun - Guangzhou CN
  • Zhang; Jiancun - San Mateo CA
  • Zhang; Jiancun - Dongguan CN
  • Zhang; Jiancun - Oakland CA
  • Zhang; Jiancun - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Long-acting prodrugs of rasagiline, preparing methods and uses thereof
Grant 11,369,583 - Zhang , et al. June 28, 2
2022-06-28
Long-acting prodrugs of entecavir, preparing methods and uses thereof
Grant 11,292,811 - Zhang , et al. April 5, 2
2022-04-05
Aromatic Heterocyclic Compound, And Pharmaceutical Composition And Use Thereof
App 20220088008 - ZHANG; Jiancun ;   et al.
2022-03-24
Cyclohexene compounds and use thereof
Grant 10,919,856 - Zhang , et al. February 16, 2
2021-02-16
Method for preparing pyrimidone compound
Grant 10,851,068 - Lin , et al. December 1, 2
2020-12-01
Long-acting Prodrugs Of Rasagiline, Preparing Methods And Uses Thereof
App 20200246302 - Kind Code
2020-08-06
Long-acting Prodrugs Of Entecavir, Preparing Methods And Uses Thereof
App 20200239513 - ZHANG; Jiancun ;   et al.
2020-07-30
Method For Preparing Pyrimidone Compound
App 20200157054 - LIN; Runfeng ;   et al.
2020-05-21
Salts of 2,6-dimethylpyrimidone derivatives and uses thereof
Grant 10,647,682 - Lin , et al.
2020-05-12
Cathepsin K inhibitors and application thereof
Grant 10,494,364 - Wang , et al. De
2019-12-03
Salts Of 2,6-dimethylpyrimidone Derivatives And Uses Thereof
App 20190308939 - LIN; Runfeng ;   et al.
2019-10-10
Cyclohexene Compounds And Use Thereof
App 20190241520 - Zhang; Jiancun ;   et al.
2019-08-08
Cyclohexene Derivative Or Pharmaceutically Acceptable Salt Thereof, And Application Of Same
App 20190167593 - Zhang; Jiancun ;   et al.
2019-06-06
Fxr Receptor Modulator, Preparation Method Therefor, And Uses Thereof
App 20190002452 - Zhang; Jiancun ;   et al.
2019-01-03
Nimodipine Water-Soluble Derivative, And Preparation Method And Use Thereof
App 20180303810 - Zhang; Jiancun ;   et al.
2018-10-25
Cathepsin K Inhibitors And Application Thereof
App 20180230138 - WANG; Xiaojun ;   et al.
2018-08-16
Compounds as CRTH2 antagonist and uses thereof
Grant 9,951,010 - Zhang , et al. April 24, 2
2018-04-24
Nitrogenous heterocyclic derivatives and their application in drugs
Grant 9,902,712 - Zhang , et al. February 27, 2
2018-02-27
Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
Grant 9,802,949 - Zhang , et al. October 31, 2
2017-10-31
Compounds As Crth2 Antagonist And Uses Thereof
App 20170267634 - ZHANG; Yingjun ;   et al.
2017-09-21
Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
Grant 9,738,629 - Zhang , et al. August 22, 2
2017-08-22
Bridged Ring Compounds As Hepatitis C Virus Inhibitors, Pharmaceutical Compositions And Uses Thereof
App 20170044140 - ZHANG; Yingjun ;   et al.
2017-02-16
Aminoquinazoline derivatives and their salts and methods of use thereof
Grant 9,556,191 - Zhang , et al. January 31, 2
2017-01-31
Nitrogenous Heterocyclic Derivatives And Their Application In Drugs
App 20160355501 - Zhang; Jiancun ;   et al.
2016-12-08
Nitrogenous heterocyclic derivatives and their application in drugs
Grant 9,434,695 - Zhang , et al. September 6, 2
2016-09-06
Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof
Grant 9,416,139 - Zhang , et al. August 16, 2
2016-08-16
Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
Grant 9,309,231 - Zhang , et al. April 12, 2
2016-04-12
Spiro compounds as Hepatitis C virus inhibitors
Grant 9,303,061 - Zhang , et al. April 5, 2
2016-04-05
Aminoquinazoline Derivatives And Their Salts And Methods Of Use Thereof
App 20160039838 - ZHANG; Yingjun ;   et al.
2016-02-11
Aminoquinazoline derivatives and their salts and methods of use
Grant 9,181,277 - Zhang , et al. November 10, 2
2015-11-10
Fused Ring Compounds As Hepatitis C Virus Inhibitors, Pharmaceutical Compositions And Uses Thereof
App 20150307509 - ZHANG; Yingjun ;   et al.
2015-10-29
Spiro Ring Compound As Hepatitis C Virus (hcv) Inhibitor And Uses Thereof
App 20150299215 - Zhang; Jiancun ;   et al.
2015-10-22
Spiro Ring Compounds As Hepatitis C Virus (hcv) Inhibitors
App 20150232509 - Zhang; Yingjun ;   et al.
2015-08-20
Nitrogenous Heterocyclic Derivatives And Their Application In Drugs
App 20150087639 - Zhang; Yingjun ;   et al.
2015-03-26
Aminoquinazoline Derivatives And Their Salts And Methods Of Use
App 20140228361 - Zhang; Jiancun ;   et al.
2014-08-14
Spiro Compounds As Hepatitis C Virus Inhibitors
App 20140147412 - Zhang; Jiancun ;   et al.
2014-05-29
Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
Grant 7,649,015 - Arimili , et al. January 19, 2
2010-01-19
Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
App 20070010489 - Arimilli; Murty N. ;   et al.
2007-01-11
Method and compositions for identifying anti-HIV therapeutic compounds
App 20050239054 - Arimilli, Murty N. ;   et al.
2005-10-27
Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
App 20050209197 - Arimilli, Murty N. ;   et al.
2005-09-22
Method for oligonucleotide analog synthesis
Grant 5,646,269 - Matteucci , et al. July 8, 1
1997-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed